Researchers at Baylor College of Medicine have identified a previously unknown defense mechanism in blood vessel cells that helps slow atherosclerosis by repairing DNA damage. The study shows that ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
RGC-32, or Response Gene to Complement 32, plays a pivotal role in mediating cellular responses following complement activation. Acting as a regulator of the cell cycle, RGC-32 is implicated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results